Certain Common Stock of HUMAN MADE Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2026. These Common Stock will be under lockup for 179 days starting from 27-NOV-2025 to 25-MAY-2026.
Details:
In connection with this offering and the underwriting purchase and underwriting sale, Tomoaki Nagao, the seller and share lender, Pharrell Williams and NIGOLD Co., Ltd., also sellers, and Brian Donnelly and Satoshi Tanaka, the stock acquisition right holders of the Company, have agreed with the joint lead managers that they will not sell, etc., the Company’s common shares (excluding, however, the underwriting purchase and underwriting sale by the underwriters, the lending of the Company’s common shares for the offering by way of over-allotment, and the acquisition by Nomura Securities Co., Ltd. of the Company’s common shares subject to the green shoe option) during the period from the execution date of the principal underwriting agreement until May 25, 2026, which is the 180th day after the listing (trading commencement) date (including that day), without the prior written consent of the joint lead managers.
Furthermore, the sellers, Matsunuma Rei, Yanagisawa Junichi and Hatoyama Reiji, have agreed with the joint lead managers that they will not sell, etc., the company’s common stock (excluding sales, etc. through purchase and underwriting by the underwriters) during the period from the date of the original underwriting agreement to November 21, 2026, which is 360 days after the listing (commencement of trading) date (including that date) without the prior written consent of the joint lead managers.
In addition, the Company has agreed with the joint lead managers that during the period from the date of the execution of the principal underwriting agreement until May 25, 2026, which is the 180th day after the listing (trading commencement) date (including that day), the Company will not issue any of its common shares, any securities that can be converted into or exchanged for its common shares, or any securities that confer the right to acquire or receive its common shares (excluding this offering, stock splits, and the issuance of stock acquisition rights as stock options, etc.) without the prior written consent of the joint lead managers.